Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 835837, 10 pages
http://dx.doi.org/10.1155/2014/835837
Research Article

Maternal Plasma and Amniotic Fluid Chemokines Screening in Fetal Down Syndrome

1Department of Perinatology and Obstetrics, Medical University of Bialystok, Marii Sklodowskiej-Curie 24a, Podlasie, 15-276 Bialystok, Poland
2Department of Reproduction and Gynecological Endocrinology, Medical University of Bialystok, Marii Sklodowskiej-Curie 24a, 15-276 Bialystok, Poland
3Department of Clinical Molecular Biology, Medical University of Bialystok, Waszyngtona 12, 15-269 Bialystok, Poland

Received 12 July 2014; Accepted 23 October 2014; Published 16 November 2014

Academic Editor: Sandra Helena Penha Oliveira

Copyright © 2014 Piotr Laudanski et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [9 citations]

The following is the list of published articles that have cited the current article.

  • Karol Charkiewicz, Agnieszka Blachnio-Zabielska, Monika Zbucka-Kretowska, Slawomir Wolczynski, and Piotr Laudanski, “Maternal Plasma and Amniotic Fluid Sphingolipids Profiling in Fetal Down Syndrome,” Plos One, vol. 10, no. 5, 2015. View at Publisher · View at Google Scholar
  • Karol Charkiewicz, Monika Zbucka-Kretowska, Joanna Goscik, Slawomir Wolczynski, Adam Lemancewicz, and Piotr Laudanski, “Brief Communication: Maternal Plasma Autoantibodies Screening in Fetal Down Syndrome,” Journal of Immunology Research, vol. 2016, pp. 1–11, 2016. View at Publisher · View at Google Scholar
  • Martina Maritati, Manola Comar, Nunzia Zanotta, Silva Seraceni, Alessandro Trentini, Fabrizio Corazza, Fortunato Vesce, and Carlo Contini, “Influence of vaginal lactoferrin administration on amniotic fluid cytokines and its role against inflammatory complications of pregnancy,” Journal of Inflammation, vol. 14, no. 1, 2017. View at Publisher · View at Google Scholar
  • Monika Zbucka-Kretowska, Karol Charkiewicz, Joanna Goscik, Slawomir Wolczynski, and Piotr Laudanski, “Maternal plasma angiogenic and inflammatory factor profiling in foetal Down syndrome,” Plos One, vol. 12, no. 12, pp. e0189762, 2017. View at Publisher · View at Google Scholar
  • Karol Charkiewicz, Elwira Jasinska, Joanna Goscik, Ewa Koc-Zorawska, Marcin Zorawski, Pawel Kuc, Grzegorz Raba, Tomasz Kluz, Jaroslaw Kalinka, Agata Sakowicz, and Piotr Laudanski, “Angiogenic factor screening in women with mild preeclampsia – New and significant proteins in plasma,” Cytokine, 2017. View at Publisher · View at Google Scholar
  • Ewa Parfieniuk, Paulina Samczuk, Tomasz Kowalczyk, Karolina Pietrowska, Magdalena Niemira, Magdalena Paczkowska-Abdulsalam, Slawomir Wolczynski, Adam Kretowski, Michal Ciborowski, and Monika Zbucka-Kretowska, “Maternal plasma metabolic fingerprint indicative for fetal Down syndrome,” Prenatal Diagnosis, 2018. View at Publisher · View at Google Scholar
  • Jan Czerniecki, Joanna Goscik, Monika Zbucka-Kretowska, Karol Charkiewicz, Slawomir Wolczynski, and Piotr Laudanski, “Amniotic Fluid Angiogenic and Inflammatory Factor Profiling in Foetal Down Syndrome,” Fetal Diagnosis and Therapy, vol. 44, no. 1, pp. 44–50, 2018. View at Publisher · View at Google Scholar
  • Haldun Arpaci, and Omer Erkan Yapca, “Amniotic fluid NF-kB concentration in pregnant women with a high risk of prenatal screening test results,” Ginekologia Polska, vol. 89, no. 10, pp. 577–580, 2018. View at Publisher · View at Google Scholar
  • Monika Zbucka-Kretowska, Magdalena Niemira, Magdalena Paczkowska-Abdulsalam, Agnieszka Bielska, Anna Szalkowska, Ewa Parfieniuk, Michal Ciborowski, Slawomir Wolczynski, and Adam Kretowski, “Prenatal circulating microRNA signatures of foetal Down syndrome,” Scientific Reports, vol. 9, no. 1, 2019. View at Publisher · View at Google Scholar